1 |
Derynck R, Zhang YE.Smad-dependent and Smad-independent pathways in TGF-β family Signalling[J].Nature,2003,425(6958):577-584.
|
2 |
Hansen KE, Cush J, Singhal Aet al.The safety and efficacy of leflunomide in combination with infliximab in rheumatoid arthritis[J].Arthritis Rheum,2004,51(2):228-232.
|
3 |
Zhang HD, Wang WM, Jin YM,et al. Effects of TGF-B1 on expression of inflammation-related chemokines in renal tubular epithelial cells[J]. Chin J Nephrol, 2008,24(2):138-139.
|
4 |
Xiao ZJ, Jia YZ, Dong JX, et al. Expression and localization of smad2/3 and P-smad2/3 in human kidney[J]. Chin J Histochem Cytochem, 2008, 17(4): 345-348.
|
5 |
Lan HY.Tubular epithelial-myofibroblast transdifferentia-tionmechanisms in proximal tubule cells[J].Curr Opin Nephro Hypertens,2003,12(1): 25-29.
|
6 |
Sun L, Zhang D, Liu F, et al.Low-dose paclitaxel ameliorates fibrosis in the remnant kidney model by down-regulating miR-192[J]. J Pathol,2011,225(3):364-377.
|
7 |
Zao D, Yu L, Weng ZY, et al. Correlation between expression of transforming growth factor β gene and response to steroid therapy in children with nephritic syndrome[J]. J Clin Pediatr, 2006, 24(4): 260-263.
|
8 |
Lin J, Wang NN, Tan RY, et al. Myofibroblast transition of human kidneytubular cells regulated by smad mediated signaling pathway[J]. Chin J Nephrol Dial Transplant, 2005, 14(3): 230-234.
|
9 |
Lu J, Liang H, Liu SZ,et al,.Action of transforming growth factor-1 in renal fibrosis on human mesengial proliferative glomerulonephritis[J]. J Zhejiang Univ, 2004,3(1):46-51.
|
10 |
Zhang JH, Chen ZQ, Sun YF,et al. Effect of herb of supplement qi and nourish yin eliminating mass and dredge nels and collaterals on the mesangial cells secreting extracellular matrix[J].Chin J Gerontol,2010,30(3):620-622.
|
11 |
Wand J, Guo JH, Meng W,et al. Expression of the TGF-β1, MMP-2 ,collage IV deposit in rental fibrosis formation in CAN and its cliniconolog significance[J].Chin J Organ Transplant, 2006,27(8):478-480.
|
12 |
Chui TG, Hou FF, Ni ZH, et al. Treatment of proliferative lupus nephritis with leflunomide and steroid a prospective multi-ceater controlled clinical trial[J]. Chin J Intern Med,2005, 44(9): 672-676.
|
13 |
Wang ZL, Wang MB, Liu P, et al.Leflunomide for idiopathic frequent-relapsing nephrotic syndrome in children[J].J Clin Nephrolog, 2012,12(1):24-25.
|
14 |
Tang Y, Lou TQ, Wang C,et al. Study on protective effects and its mechanism of leflunomide on renal tissue in rat IgA nephropathy model[J].Chin Critic Care Med, 2008,20(5):283-286.
|
15 |
Xu L, LYU XH, Ne RH, et al. The effect of leflunomide on renal expression of TGF-β1 in rats with 5/6 nephrectomy[J]. Chin J Integrat Tradition West Nephrol, 2009, 10(5): 409-412.
|